NCT00971620 2017-04-07
Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
Clinical Trials
1 trialsHas results × Hereditary leiomyomatosis and renal cell cancer × Botulinum Toxins, Type A × Clear all